{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:52:38Z","timestamp":1773154358890,"version":"3.50.1"},"reference-count":45,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"4","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2007]]},"DOI":"10.2133\/dmpk.22.313","type":"journal-article","created":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T05:50:32Z","timestamp":1189057832000},"page":"313-321","source":"Crossref","is-referenced-by-count":28,"title":["Decreased Intestinal CYP3A and P-glycoprote\u00een Activities in Rats with Adjuvant Arthritis"],"prefix":"10.2133","volume":"22","author":[{"given":"Satoshi","family":"Uno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadatoshi","family":"Tanino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.22.313_bb0005","first-page":"1232","article-title":"Physiological and pathophysiological regulation of cytochrome P450","volume":"26","author":"Morgan","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.22.313_bb0010","first-page":"268","article-title":"Regulation of the multidrug resistance genes by stress signals","volume":"3","author":"Sukhai","year":"2000","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.2133\/dmpk.22.313_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0006-2952(92)90047-M","article-title":"Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat","volume":"44","author":"Chen","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.2133\/dmpk.22.313_bb0020","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/03602539709002246","article-title":"Regulation of cytochromes P450 during inflammation and infection","volume":"29","author":"Morgan","year":"1997","journal-title":"Drug Metab. Rev."},{"key":"10.2133\/dmpk.22.313_bb0025","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1172\/JCI117582","article-title":"Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism","volume":"94","author":"Shedlofsky","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.2133\/dmpk.22.313_bb0030","series-title":"Cytochrome P450: Metabolic and Toxicological Aspects","first-page":"241","article-title":"The CYP3A family","author":"Manuel","year":"1996"},{"key":"10.2133\/dmpk.22.313_bb0035","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/js980082d","article-title":"Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics","volume":"87","author":"Wacher","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.22.313_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1472-8206.1989.tb00667.x","article-title":"Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat","volume":"3","author":"Belpaire","year":"1989","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.2133\/dmpk.22.313_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/chir.530060508","article-title":"Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat","volume":"6","author":"Laethem","year":"1994","journal-title":"Chirality"},{"key":"10.2133\/dmpk.22.313_bb0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF02028122","article-title":"Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats","volume":"37","author":"Piquette-Miller","year":"1992","journal-title":"Agents Actions"},{"key":"10.2133\/dmpk.22.313_bb0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1023\/A:1018907431893","article-title":"Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay","volume":"10","author":"Piquette-Miller","year":"1993","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.22.313_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2125.2000.00314.x","article-title":"Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis","volume":"50","author":"Mayo","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.22.313_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0960-0760(98)00008-9","article-title":"Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands","volume":"66","author":"Marsaud","year":"1998","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.2133\/dmpk.22.313_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00126-5","article-title":"Active secretion and enterocytic drug metabolism barriers to drug absorption","volume":"46","author":"Wacher","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.2133\/dmpk.22.313_bb0075","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1073\/pnas.89.20.9784","article-title":"Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis","volume":"89","author":"Williams","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.2133\/dmpk.22.313_bb0080","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1248\/bpb.16.1130","article-title":"Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states","volume":"16","author":"Shibata","year":"1993","journal-title":"Biol. Pharm. Bull."},{"key":"10.2133\/dmpk.22.313_bb0085","first-page":"253","article-title":"Prolonged pentobarbital sleeping time in adjuvant-induced polyarthritic rats","volume":"9","author":"Dipasquale","year":"1974","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.2133\/dmpk.22.313_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11095-004-9010-6","article-title":"Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain","volume":"22","author":"Projean","year":"2005","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.22.313_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0928-0987(02)00052-0","article-title":"Tissue-specific regulation of expression and activity of P-glycoprotein in adjuvant arthritis rats","volume":"16","author":"Achira","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.2133\/dmpk.22.313_bb0100","first-page":"1550","article-title":"Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats","volume":"273","author":"Philippe","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.2133\/dmpk.22.313_bb0105","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/jps.20072","article-title":"Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells","volume":"93","author":"Belliard","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.22.313_bb0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2133\/dmpk.17.427","article-title":"Species difference in nisoldipine oxidation activity in the small intestine","volume":"17","author":"Komura","year":"2002","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.2133\/dmpk.22.313_bb0115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1023\/A:1023485519485","article-title":"Differential effect of acute hepatic failure on in vivo and in vitro P-glycoprotein functions in the intestine","volume":"20","author":"Yumoto","year":"2003","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.22.313_bb0120","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1023\/A:1016005212640","article-title":"Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers","volume":"13","author":"Hosoya","year":"1996","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.22.313_bb0125","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1023\/A:1020448430919","article-title":"Transdermal use of phosphorodiamidate morpholino oligomer AVI-4472 inhibits cytochrome P450 3A2 activity in male rats","volume":"19","author":"Arora","year":"2002","journal-title":"Pharm. Res."},{"key":"10.2133\/dmpk.22.313_bb0130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3565(24)29211-9","article-title":"Midazolam is a phenobarbital-like cytochrome p450 inducer in rats","volume":"299","author":"Hoen","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.22.313_bb0135","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/jpet.301.2.586","article-title":"Intestinal metabolism promotes regional differences in apical up-take of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat","volume":"301","author":"Li","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.22.313_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/jsre.2002.6359","article-title":"Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus","volume":"103","author":"Shimomura","year":"2002","journal-title":"J. Surg. Res."},{"key":"10.2133\/dmpk.22.313_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2004.09.002","article-title":"Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes","volume":"23","author":"Lacombe","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.2133\/dmpk.22.313_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0009-9236(96)90162-9","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.22.313_bb0155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0009-9236(96)90177-0","article-title":"Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism","volume":"59","author":"Thummel","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.22.313_bb0160","first-page":"207","article-title":"Regulation of cytochrome p450 by inflammatory mediators: why and how?","volume":"29","author":"Morgan","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.22.313_bb0165","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/00498250110074063","article-title":"Evaluation of 7-benzylox-y-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxy-quinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes","volume":"31","author":"Renwick","year":"2001","journal-title":"Xenobiotica"},{"key":"10.2133\/dmpk.22.313_bb0170","first-page":"940","article-title":"Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450","volume":"24","author":"Ghosal","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.22.313_bb0175","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/jpet.103.061671","article-title":"Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat","volume":"309","author":"Matsubara","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.22.313_bb0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bjp.0701148","article-title":"Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha","volume":"121","author":"Woolf","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.2133\/dmpk.22.313_bb0185","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/35068566","article-title":"Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity","volume":"410","author":"Samad","year":"2001","journal-title":"Nature"},{"key":"10.2133\/dmpk.22.313_bb0190","first-page":"1431","article-title":"Tumor necrosis factor-alpha and fever after peripheral inflammation in the rat","volume":"267","author":"Cooper","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.2133\/dmpk.22.313_bb0195","first-page":"862","article-title":"Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-alpha in the rat","volume":"272","author":"Luheshi","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.2133\/dmpk.22.313_bb0200","series-title":"Cytokins and Pain","first-page":"1","author":"Dinarello","year":"1999"},{"key":"10.2133\/dmpk.22.313_bb0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.2133\/dmpk.22.313_bb0210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U","article-title":"Cytokines and the hepatic acute phase response","volume":"181","author":"Moshage","year":"1997","journal-title":"J. Pathol."},{"key":"10.2133\/dmpk.22.313_bb0215","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/1520-6017(200105)90:5<638::AID-JPS1020>3.0.CO;2-L","article-title":"Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells","volume":"90","author":"Bertilsson","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.2133\/dmpk.22.313_bb0220","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/dmd.106.011536","article-title":"Effects of alterations in CAR on bilirubin detoxification in mouse collagen-induced arthritis","volume":"35","author":"Kawase","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.22.313_bb0225","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/bbrc.2000.3219","article-title":"Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes","volume":"274","author":"Pascussi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715302664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715302664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T21:23:12Z","timestamp":1737408192000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715302664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"alternative-id":["S1347436715302664"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.22.313","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}